Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP) : a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
In: The Lancet Neurology, Vol. 23 (2024), No. 1, pp. 46 - 59
2024article/chapter in journalClosed access
MedicineFaculty of Medicine » Essen University Hospital » Institute of Computer Science in Medicine, Biostatistics, and Epidemiology
Related: 1 publication(s)
Title in English:
Safety and efficacy of factor XIa inhibition with milvexian for secondary stroke prevention (AXIOMATIC-SSP) : a phase 2, international, randomised, double-blind, placebo-controlled, dose-finding trial
Author:
Sharma, Mukul
- Other
- corresponding author
- GND
- 11811901X
- LSF ID
- 13450
- ORCID
- 0000-0002-6556-8612
- Other
- connected with university
Year of publication:
2024
Open Access?:
Closed access
Web of Science ID
PubMed ID
Scopus ID
Language of text:
English
Type of resource:
Text